UM

Browse/Search Results:  1-2 of 2 Help

Selected(0)Clear Items/Page:    Sort:
Inhibitory activity of cetuximab on epidermal growth factor receptor mutations in non-small cell lung cancers Journal article
Molecular Cancer Therapeutics, 2007,Volume: 6,Issue: 10,Page: 2642-2651
Authors:  Doody J.F.;  Wang Y.;  Patel S.N.;  Joynes C.;  Sui P.L.;  Gerlak J.;  Rolser R.L.;  Li Y.;  Steiner P.;  Bassi R.;  Hicklin D.J.;  Hadari Y.R.
Favorite |  | TC[WOS]:44 TC[Scopus]:49 | Submit date:2019/01/16
Synthesis and structure-activity relationships of 1,2,4-triazoles as a novel class of potent tubulin polymerization inhibitors Journal article
Bioorganic and Medicinal Chemistry Letters, 2005,Volume: 15,Issue: 23,Page: 5154-5159
Authors:  Ouyang X.;  Chen X.;  Piatnitski E.L.;  Kiselyov A.S.;  He H.-Y.;  Mao Y.;  Pattaropong V.;  Yu Y.;  Kim K.H.;  Kincaid J.;  Smith II L.;  Wong W.C.;  Lee S.P.;  Milligan D.L.;  Malikzay A.;  Fleming J.;  Gerlak J.;  Deevi D.;  Doody J.F.;  Chiang H.-H.;  Patel S.N.;  Wang Y.;  Rolser R.L.;  Kussie P.;  Labelle M.;  Tuma M.C.
Favorite |  | TC[WOS]:56 TC[Scopus]:60 | Submit date:2019/01/16
1,2,4-Triazole  Antimitotic  Tubulin inhibitor  Tubulin polymerization  Tumor vasculature  Vascular disrupting agent